Letter: Cytarabine: therapeutic trials and editorial standards.
D003561:Cytarabine / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D012075:Remission, Spontaneous
D003561:Cytarabine